Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,661 | 6,719 | 1,353 | 858 | 1,530 |
| Receivables | 285 | 800 | 80 | 67 | 348 |
| TOTAL | $6,056 | $7,568 | $1,494 | $1,000 | $1,936 |
| Non-Current Assets | |||||
| PPE Net | 73 | 65 | 37 | 24 | 21 |
| Other Non-Current Assets | 257 | 266 | 271 | 0 | 0 |
| TOTAL | $330 | $332 | $308 | $24 | $21 |
| Total Assets | $6,386 | $7,900 | $1,802 | $1,024 | $1,957 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,239 | 1,106 | 919 | 675 | 1,019 |
| Other current liabilities | N/A | N/A | 84 | N/A | N/A |
| TOTAL | $1,239 | $1,106 | $1,003 | $675 | $1,019 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,683 | 2,061 | 0 | 380 | 206 |
| TOTAL | $3,683 | $2,061 | $N/A | $380 | $206 |
| Total Liabilities | $4,921 | $3,167 | $1,003 | $1,055 | $1,225 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,833 | 7,815 | 6,371 | 6,055 | 6,055 |
| Common Shares | 49,031 | 48,943 | N/A | 42,723 | 42,723 |
| Retained earnings | -55,026 | -51,464 | -40,234 | -49,984 | -49,088 |
| Other shareholders' equity | 498 | 584 | 0 | 761 | 778 |
| TOTAL | $1,465 | $4,733 | $799 | $-31 | $732 |
| Total Liabilities And Equity | $6,386 | $7,900 | $1,802 | $1,024 | $1,957 |